Navigation Links
Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space
Date:10/16/2008

AMES, Iowa, Oct. 16 /PRNewswire/ -- Advanced Analytical Technologies, Inc. (AATI), based in Ames, IA will expand its office and production space, adding an additional 1200 ft2 of space to current operations. The expansion adjoins the current office space the company occupies in Building 4 on the ISU Research Park campus. Although the 35 person, 10 year old analytical instrumentation company will continue to occupy space in 2 building on the Research Park Campus, the expansion will make the company more efficient by bringing together key operational units.

Dr. Steven J Lasky, CEO of AATI, states, "We are excited about this expansion. The new production space that we are adding will allow us to not only make but QC all of our instruments under one roof, something that we could not do previously. Additionally the space will bring together the management team and support staff and will provide room for new hires as we grow over the next several years."

Mr. Steve Carter, Director of the ISU Research Park, states, "The expansion is also good for the Research Park. We are continuing to fulfill our mission of helping emerging companies with affordable research space and services. Advanced Analytical is one of the many success stories benefiting from the foresight of State leaders. Expansions by companies usually correspond with the addition of new positions, which is obviously a win/win situation for the State of Iowa, ISU and Advanced Analytical."

About Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) provides innovative solutions to improve processes and accelerate research within the pharmaceutical, life science, and personal care/OTC markets. AATI's portfolio includes technologies for the rapid detection and enumeration of microbes by flow cytometry, and the parallel analysis of pharmaceutical compounds or biomolecules by capillary electrophoresis with UV absorbance detection. Several new instruments based on fluorescent multichannel CE are being designed and will be introduced in 2009.

For more information visit the company's website at http://www.aati-us.com or contact us at webinfo@aati-us.com

CONTACT

Steve Siembieda

2711 S. Loop Dr.

Ames, IA 50010

Phone: 515-296-6600

http://www.aati-us.com

webinfo@aati-us.com


'/>"/>
SOURCE Advanced Analytical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Acknowledges ISTO Technologies Role in Developing Advanced Biologic Products for Bone Healing
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels
4. Advanced Instruments Acquires D & F Control Systems Inc.
5. Advanced Life Sciences to Host Conference Call to Update Investors on Progress of Corporate Initiatives on October 1, 2008
6. Advanced Chemical Transport Opens Merced Facility
7. Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
8. Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services
9. Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment
10. Waters Brings Advanced Laboratory Data Management to Microsofts BioIT Alliance
11. LUMEDX Introduces Advanced Multi-Modality, Multi-Vendor, Web-Enabled ECG Management Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... Surface Plasmon Resonance (SPR) is ... optical phenomenon that is sensitive to changes in the dielectric properties of the medium ... changes in refractive index occurring up to 300 nm above the metal surface (Au) ...
(Date:2/28/2017)... 2017  Phosphorus, a computational genomics and clinical ... the Phosphorus Scientific Advisory Board, an established group ... the company on the development of new products ... visit http://phosphorus.com/about-us/ to learn more about ... gathered some of the top leaders in the ...
(Date:2/28/2017)... 28, 2017  Xencor, Inc. (NASDAQ: XNCR), a clinical-stage ... treatment of autoimmune diseases, asthma and allergic diseases ... fourth quarter and full year ended December 31, ... recent business and clinical highlights. "During ... development pipeline by starting five clinical trials across ...
(Date:2/28/2017)... MA (PRWEB) , ... February 28, 2017 , ... ... clinical trials, yet requires extensive coordination and expertise. Colpitts Clinical Trial Travel ... celebrating 15 years of meeting this unique need within the biotechnology and pharmaceutical ...
Breaking Biology Technology:
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/13/2017)... 2017 Former 9/11 Commission border counsel and ... Janice Kephart of Identity Strategy Partners, LLP, today ... "Executive Order: Protecting the Nation From Foreign Terrorist ... "As President Trump,s ,Travel Ban, Executive Order gains ... banned the travel ban, it is important that our ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):